PT Merck Tbk (ISX:MERK) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:MERK PT Merck Tbk ISX:MERK
84 GF Score
Price Rp3,760.00
GF Value Rp4,944.61
Valuation Modestly Undervalued
View Full Analysis

What is PT Merck Tbk Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

PT Merck Tbk Valuation Rank Related Terms

ISX:MERK
84GF Score
PT Merck Tbk ISX:MERK
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PT Merck Tbk (ISX:MERK) Overvalued in 2026?

Based on GuruFocus' analysis, PT Merck Tbk stock appears to be undervalued. The current stock price of Rp3,760.00 is trading 24% below its estimated GF Value™ of Rp4,944.61. GuruFocus considers PT Merck Tbk to be Modestly Undervalued.

Key valuation signals for ISX:MERK:

  • Valuation Rank:
  • GF Value™: Rp4,944.61 vs. price of Rp3,760.00 (24% below fair value)
  • GF Score™: 84/100

No single metric tells the full story. See the ISX:MERK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Merck Tbk Business Description

Address Jalan T.B. Simatupang No. 8, Pasar Rebo, Jakarta Timur, IDN, 13760
PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia. The company operates in three segments: Biopharma, Consumer Health, and Others. The company offers pharmaceutical and biological prescription medicines for colorectal cancer, head and neck tumors, multiple sclerosis, infertility, growth hormone disorders, cardiovascular disorders, diabetes, as well as thyroid disorders such as hypothyroidism.
84GF Score

Get the complete analysis for ISX:MERK

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp3,760.00
Price
Rp4,944.61
GF Value